Royal Marsden NHS Foundation Trust
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
Proof-of-concept Study of Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma
- First Posted Date
- 2016-08-31
- Last Posted Date
- 2019-09-18
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 17
- Registration Number
- NCT02884453
- Locations
- 🇬🇧
The Royal Marsden NHS Trust, Sutton, Surrey, United Kingdom
PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck
Phase 1
Terminated
- Conditions
- Squamous Cell Carcinoma of the Head and NeckSquamous Cell Carcinoma
- Interventions
- First Posted Date
- 2016-06-30
- Last Posted Date
- 2022-01-13
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 3
- Registration Number
- NCT02819752
- Locations
- 🇬🇧
Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom
The HeartSpare Study (Stage I)
Phase 2
Completed
- Conditions
- Breast Cancer
- Interventions
- Procedure: Voluntary deep-inspiratory breath holdProcedure: Prone treatmentDevice: Active-breathing-controlled deep-inspiratory breathhold
- First Posted Date
- 2016-06-09
- Last Posted Date
- 2016-06-09
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 57
- Registration Number
- NCT02794324
- Locations
- 🇬🇧
The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom
The HeartSpare Plus 1B Trial
Phase 2
Completed
- Conditions
- Breast Cancer
- Interventions
- Radiation: VMAT_FBRadiation: WT_vDIBH
- First Posted Date
- 2016-05-13
- Last Posted Date
- 2022-04-19
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 39
- Registration Number
- NCT02771353
Primary Radiotherapy And DIEP flAp Reconstruction Trial
Not Applicable
Completed
- Conditions
- Breast Cancer
- Interventions
- Other: Radiotherapy before surgery
- First Posted Date
- 2016-05-13
- Last Posted Date
- 2022-05-02
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 33
- Registration Number
- NCT02771938
- Locations
- 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom
Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases
Phase 2
Active, not recruiting
- Conditions
- Carcinoma, Non-Small-Cell LungProstate CancerBreast Cancer
- Interventions
- Other: Standard of CareRadiation: SBRT
- First Posted Date
- 2016-05-03
- Last Posted Date
- 2019-08-21
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 245
- Registration Number
- NCT02759783
- Locations
- 🇬🇧
The Christie Hospital, Manchester, United Kingdom
🇬🇧Queen Elizabeth Hospital, Birmingham, United Kingdom
🇦🇺Calvary Mater Newcastle, Waratah, New South Wales, Australia
Tenovus Cancer Choirs Study: the Benefits of Singing for Those Affected by Cancer
Not Applicable
- Conditions
- Cancer
- Interventions
- Other: Tenovus Cancer Choir
- First Posted Date
- 2016-04-29
- Last Posted Date
- 2016-04-29
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 420
- Registration Number
- NCT02756780
- Locations
- 🇬🇧
Royal Marsden Hospital NHS Foundation Trust, London/Surrey, United Kingdom
Developing a Symptom List for Children With Cancer
- Conditions
- Paediatric Oncology Palliative Care
- First Posted Date
- 2016-04-04
- Last Posted Date
- 2016-04-04
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 40
- Registration Number
- NCT02726815
- Locations
- 🇬🇧
Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
Art Therapy for Pain Relief in Breast Cancer Patients
- Conditions
- Pain
- Interventions
- Other: Art Therapy Group
- First Posted Date
- 2016-02-11
- Last Posted Date
- 2018-05-01
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 20
- Registration Number
- NCT02680236
- Locations
- 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom
Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy Trial
Phase 2
Recruiting
- Conditions
- Adenocarcinoma of the StomachAdenocarcinoma of the OesophagusAdenocarcinoma of the Gastro-oesophageal Junction
- Interventions
- First Posted Date
- 2016-02-09
- Last Posted Date
- 2023-05-15
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 924
- Registration Number
- NCT02678182
- Locations
- 🇬🇧
The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Sutton, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath